Moshe Portnoy
6Patents
3h-index
8Co-inventors
46Inventor score
Filing activity: Nov 17, 2005 → Jul 5, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8394790B2 | Psychotropic agents having glutamate NMDA activity | Chemistry; Metallurgy | 21 | Active |
| US8828993B2 | Psychotropic agents having glutamate NMDA activity | Chemistry; Metallurgy | 7 | Active |
| US7378432B2 | Glycogen synthase kinase-3 inhibitors | Chemistry; Metallurgy | 5 | Expired |
| US11104651B2 | PERK inhibitors and uses thereof in treating diseases associated with aggregation-prone proteins | Human Necessities | 0 | Active |
| US10723706B2 | Perk inhibitors and uses thereof in treating diseases associated with aggregation-prone proteins | Human Necessities | 0 | Active |
| US8088941B2 | Glycogen synthase kinase-3 inhibitors | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.